SCHEMBL25925915

SCHEMBL25925915

Cc1nsc(/N=N/c2ccc(O)cc2O)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.54
KMT2A Q03164 7/20 0.54
MAPT P10636 6/20 0.54
POLB P06746 5/20 0.54
L3MBTL1 Q9Y468 4/20 0.54
NPSR1 Q6W5P4 2/20 0.54
MAPK1 P28482 2/20 0.54
KDM4E B2RXH2 2/20 0.54
IDO1 P14902 1/20 0.54
TDO2 P48775 1/20 0.54
GFER P55789 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
EGFR P00533 1/20 0.49
NPC1 O15118 5/20 0.44
RAB9A P51151 5/20 0.44
ALDH1A1 P00352 4/20 0.44
HTT P42858 2/20 0.39
LMNA P02545 1/20 0.39
NSD2 O96028 2/20 0.37
MMP14 P50281 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13900096 0.85 L3MBTL1 (0.38) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL25926066 0.82 KCNH2 (0.51) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL25925913 0.81 MEN1 (0.50) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL15049576 0.77 MEN1 (0.32) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL14255076 0.74 HPGD (0.34) L3MBTL1HSP90AA1CCR6HPGD
SCHEMBL13994757 0.74 ALDH1A1 (0.41) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL14002726 0.74 ALDH1A1 (0.41) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL25925934 0.73 PTGS2 (0.41) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL25925864 0.73 L3MBTL1 (0.35) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL28348178 0.72 MAPT (0.49) MEN1KMT2AMAPTPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 MEN1 67/4885KMT2A 1814/4885MAPT 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.